Saturday, October 3, 2026

Coinbase Stock 9.58% Up On Wednesday

Coinbase Stock 9.58% Up On Wednesday

(VIANEWS) - The NASDAQ ended the session with Coinbase (COIN) jumping 9.58% to $237.54 on Wednesday while NASDAQ jumped 0.58% to $16,031.54.

Coinbase's last close was $216.77, 15.68% higher than its 52-week high of $187.39.

About Coinbase

Coinbase Global, Inc. provides financial infrastructure and technology for the crypto economy in the United States and internationally. The company offers the primary financial account in the crypto economy for consumers; and a marketplace with a pool of liquidity for transacting in crypto assets for institutions. It also provides technology and services that enable developers to build crypto products and securely accept crypto assets as payment. The company was founded in 2012 and is based in Wilmington, Delaware.

Earnings Per Share

As for profitability, Coinbase has a trailing twelve months EPS of $0.37.

PE Ratio

Coinbase has a trailing twelve months price to earnings ratio of 642. Meaning, the purchaser of the share is investing $642 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -12.74%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Coinbase's stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

Coinbase's stock is valued at $237.54 at 17:05 EST, way above its 52-week high of $187.39.

Volatility

Coinbase's last week, last month's, and last quarter's current intraday variation average was 4.61%, 3.81%, and 4.39%.

Coinbase's highest amplitude of average volatility was 4.61% (last week), 5.88% (last month), and 4.39% (last quarter).

Volume

Today's last reported volume for Coinbase is 14271600 which is 2.57% below its average volume of 14648200.

More news about Coinbase (COIN).

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com